This dose represents a significant jump and is where many patients experience their most dramatic weight loss phase
When you stop taking it, these effects disappear
Increased heart rate is also a recognised class effect, and risks such as pancreatitis and gallbladder disease are associated with this drug class
There are a lot of questions about these meds: how they compare, which might work better, and which is the safest
Ideal Candidates People who may see the greatest benefit from Retatrutide include those with: Significant weight to lose who have not achieved goals with lifestyle changes alone Type 2 diabetes or prediabetes requiring additional metabolic support Obesity-related health conditions that would improve with substantial weight loss Previous limited success with single or dual-receptor medications Important Considerations Retatrutide may not be appropriate for everyone
The drug is being developed by Eli Lilly and Company, which has announced plans to progress retatrutide into Phase 3 clinical trials across multiple indications, including obesity, type 2 diabetes, and liver disease
